Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. We employ about 43,100 people in 80 countries and market our products in around 170 countries.
Products and Services Offered
Pharmaceuticals
Category
Pharmaceutical
Target Market
Dietary, Surgical
Contact Information
Jamie Glonek
Director, Public Affairs
Market Access & Public Affairs
JWGK@novonordisk.com